HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta Working To Combat Surging Retail Theft As Q1 Sales Rise 12.3%

Executive Summary

Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.” The company is implementing additional mitigation strategies in its stores – including placing fragrances in locked cabinets – to combat organized retail theft that is expected to slightly reduce its operating margins for the full year.

You may also be interested in...



Ulta Expanding Its Youth-Targeted Luxe Platform, Exclusive Prestige Beauty Offerings

Ulta Beauty will add to its Ulta-only collections in the fiscal 2023 third quarter, bringing on cosmetics brands developed by the founders of Too Faced and Puig’s Paco Rabanne, while growing its new luxe beauty platform, installed in 200 stores so far. Net sales in the second quarter rose 10%.

Ulta: Beauty Market’s ‘Unprecedented’ Growth Reflects New Trends, Not Just Pandemic Rebound

Growth over the last two years reflects new market dynamics and a growing connection between beauty and wellness, in addition to a return to sales following pandemic-related shutdowns, Ulta Beauty leaders said in a fourth-quarter sales and earnings presentation.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel